Literature DB >> 22246647

T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations.

Hiroki Haradome1, Luigi Grazioli, Mario Morone, Sebastiana Gambarini, Thomas C Kwee, Taro Takahara, Stefano Colagrande.   

Abstract

PURPOSE: To compare the diagnostic accuracies of diffusion-weighted imaging (DWI), T2-weighted imaging (T2WI), and the combination of both sequences in discriminating benign from malignant focal liver lesions (FLLs).
MATERIALS AND METHODS: In all, 166 patients with 269 FLLs (153 benign and 116 malignant) were retrospectively evaluated. Two abdominal readers visually assessed the DWI, T2WI, and the combined (DWI+T2WI) image sets in an independent and blinded manner. The diagnostic abilities of each image set in discriminating the benign from the malignant FLLs set were compared using a binary logistic regression model. Pathologic results, consensus reading, and follow-up imaging were used as the reference standard.
RESULTS: The overall characterization accuracy in all lesions of the combined set (80.3%) was significantly higher than those of the T2WI set (68.8%) and DWI set (73.2%) (combined vs. T2WI, P < 0.001; combined vs. DWI, P = 0.001), while there was no significant difference between the T2WI and DWI sets (P = 0.058). All image sets were more accurate in the characterization of malignant FLLs than of benign FLLs (P < 0.001).
CONCLUSION: T2WI and DWI are complementary in discriminating benign from malignant FLLs; their combination improves diagnostic confidence.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22246647     DOI: 10.1002/jmri.23573

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

Review 1.  Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.

Authors:  Zhi-Guang Chen; Li Xu; Si-Wei Zhang; Yan Huang; Rui-Huan Pan
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Diffusion weighted magnetic resonance imaging and its recent trend-a survey.

Authors:  Geetha Soujanya Chilla; Cher Heng Tan; Chenjie Xu; Chueh Loo Poh
Journal:  Quant Imaging Med Surg       Date:  2015-06

Review 3.  Functional MRI and CT biomarkers in oncology.

Authors:  J M Winfield; G S Payne; N M deSouza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-13       Impact factor: 9.236

4.  Free-Breathing Liver Magnetic Resonance Imaging With Respiratory Frequency-Modulated Continuous-Wave Radar-Trigger Technique: A Preliminary Study.

Authors:  Xinyue Liang; Zhenghong Bi; Chun Yang; Ruofan Sheng; Xinyuan Xia; Zheng Zhang; Yongming Dai; Mengsu Zeng
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

5.  Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.

Authors:  Simone Maurea; Pier Paolo Mainenti; Annamaria Tambasco; Massimo Imbriaco; Carmine Mollica; Ettore Laccetti; Luigi Camera; Raffaele Liuzzi; Marco Salvatore
Journal:  Quant Imaging Med Surg       Date:  2014-06

6.  Liver diffusion-weighted MR imaging with L1-regularized iterative sensitivity encoding reconstruction based on single-shot echo-planar imaging: initial clinical experience.

Authors:  Maike Bode; Shuo Zhang; Mark N Terwolbeck; Caroline Molavi Tabrizi; Masami Yoneyama; Nils A Kraemer; Christiane K Kuhl; Alexandra Barabasch
Journal:  Sci Rep       Date:  2022-07-21       Impact factor: 4.996

7.  Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging.

Authors:  Yukihisa Takayama; Akihiro Nishie; Daisuke Okamoto; Nobuhiro Fujita; Yoshiki Asayama; Yasuhiro Ushijima; Tomoharu Yoshizumi; Masami Yoneyama; Kousei Ishigami
Journal:  Magn Reson Med Sci       Date:  2021-04-20       Impact factor: 2.760

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.